Felodipine Extended-release Tablets · FELODIPINE 5 mg/1 · Tablet, Extended Release · Oral · Yiling Pharmaceutical Inc.
NDC 69117-0029-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.1890 per unit over the past year. One of its named manufacturing plants, Yiling Pharmaceutical Ltd, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Yiling Pharmaceutical Inc. | FELODIPINE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Yiling Pharmaceutical Inc. | FELODIPINE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Yiling Pharmaceutical Inc. | FELODIPINE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Felodipine — NDC 69117-0029-01," retrieved September 3, 2026, https://drugdashboards.com/drug/69117002901.
Free to cite with attribution — see how the data is put together.